A literature review found pneumococcal conjugate vaccines were associated with some protection against flu and other viral respiratory tract infections.
The results of a randomized trial suggests rapid syndromic PCR tests could complement or replace culture-based diagnostic methods for pneumonia.
At least half of US adults hospitalized with uncomplicated community-acquired pneumonia in 2020 received 7 days or more of antibiotics.
Researchers say antibiotic trials in children diagnosed as having community-acquired pneumonia likely include many children without radiographic pneumonia.
Investigators say the strategy is readily applicable in low- and middle-income countries, where high rates of ventilator-associated pneumonia drive antibiotic use.
The goal of the intervention was to reduce diagnostic error for ventilator-associated pneumonia.
If approved, V116 would be the first pneumococcal conjugate vaccine specifically designed for adults.
Hospital-acquired pneumonia, is the most common nosocomial infection—and the deadliest.
In the COVID-19 pandemic years 2020 to 2021, IPD incidence dipped to a low of 1.6 per 100,000 children.
The level is slightly higher in school-age kids, but similar to the prepandemic period.